
Loading, please wait...

Loading, please wait...

The field of diagnostic biophotonics is rapidly advancing through enhanced infrared photon upconversion. Recently, researchers developed a core-shell nanocrystal model that significantly improves light emission. This technology allows scientists to manipulate energy transfer at the atomic level. Consequently, it overcomes the long-standing challenge of concentration quenching in medical imaging agents.
Traditional nanoparticles often lose energy through nonradiative paths, which reduces their effectiveness. However, this new design utilizes selective interfacial energy transfer (IET) between Erbium (Er) and Ytterbium (Yb) sublattices. This approach enables 100% doping of both activators and sensitizers within a single nanocrystal. As a result, the luminescence intensity increases by two orders of magnitude compared to conventional particles. Furthermore, the temporal tuning of energy channels allows for real-time red-to-green color switching.
Improving the efficiency of infrared photon upconversion has direct implications for deep-tissue photodetection. Since near-infrared light penetrates human tissue more effectively than visible light, these bright nanocrystals provide much clearer images. Moreover, oncologists might use this high-intensity emission to trigger photodynamic therapies with greater precision and lower laser power. Therefore, this breakthrough offers a transformative tool for both radiology and targeted cancer treatments.
Enhanced upconversion provides much brighter signals from deeper within biological tissues. This allows for higher contrast and better resolution in diagnostic scans compared to standard fluorescent dyes, which often suffer from background noise.
Yes, these nanocrystals can convert deep-penetrating infrared light into visible or ultraviolet light within the body. This process can be utilized to activate photosensitizing drugs to destroy tumor cells specifically while sparing healthy tissue.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Refer to the latest local and national guidelines for clinical practice.
References
Wei H et al. Boosting Upconversion through Selective Interfacial Energy Transfer toward Infrared Sub-bandgap Photodetection. Nano Lett. 2026 Apr 29. doi: 10.1021/acs.nanolett.6c01276. PMID: 42052898.
Yin L et al. Applications of upconversion nanoparticles in imaging, detection and therapy. Nanomedicine (Lond). 2011 Sep;6(7):1273-88. doi: 10.2217/nnm.11.108.
Amoozadeh M et al. Photothermal applications of upconversion nanoparticles. RSC Adv. 2025;15:21582. doi: 10.1039/D5RA02303C.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers boost upconversion intensity by 100-fold using atomic-level energy transfer, paving the way for advanced infrared medical imaging and diagnostic...
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today